Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
about
Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@en
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@nl
type
label
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@en
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@nl
prefLabel
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@en
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@nl
P2093
P2860
P356
P1476
Metformin-associated preventio ...... ebo-controlled 4.3-year trial.
@en
P2093
Cees van der Schans
Harriët Jager-Wittenaar
Ida Miedema
Mattijs Out
Philippe Lehert
Wim Krijnen
P2860
P304
P356
10.1111/DOM.13054
P577
2017-07-06T00:00:00Z